Clifton, NJ 的 多發性骨髓瘤 臨床試驗
14 項針對 多發性骨髓瘤 的研究正在 Clifton（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
招募中1/2 期
- Hackensack University Medical Center, Hackensack · 距離 7 英里
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
招募中4 期
- Hackensack University Medical Center, Hackensack · 距離 7 英里
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
招募中1 期
- Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 距離 7 英里
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- Hackensack Meridian Health, Hackensack · 距離 7 英里
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
招募中2 期
- John Theurer Cancer Center, Hackensack · 距離 7 英里
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
招募中1/2 期
- Hackensack University Medical Center, Hackensack · 距離 7 英里
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 距離 7 英里
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
招募中1/2 期
- Research Site, Hackensack · 距離 7 英里
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- Hackensack University Medical Center, Hackensack · 距離 7 英里
Mosaic Trial for Stem Cell Transplant Recipients
招募中
- Hackensack Meridian Health, Nutley · 距離 3 英里
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
招募中1 期
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 距離 7 英里
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
招募中3 期
- GSK Investigational Site, Hackensack · 距離 7 英里
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
招募中1 期
- Hackensack Meridian John Theurer Cancer Center, Hackensack · 距離 7 英里
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
招募中1/2 期
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 距離 7 英里
其他城市的 多發性骨髓瘤 試驗
- New York City, NY60 項研究
- Boston, MA42 項研究
- Atlanta, GA42 項研究
- Houston, TX38 項研究
- Durham, NC37 項研究
- Nashville, TN32 項研究
- Denver, CO27 項研究
- St. Louis, MO24 項研究
- Rochester, MN24 項研究
- Columbus, OH24 項研究
- Baldwin Park, CA23 項研究
- Edison, NJ22 項研究
Clifton 的其他研究
- 非小細胞肺癌24 項研究
- 癌症（所有類型）15 項研究
- 轉移性癌症12 項研究
- 急性髓系白血病12 項研究
- 乳癌12 項研究
- 前列腺癌12 項研究
- 卵巢癌11 項研究
- 肺癌10 項研究
- 大腸直腸癌8 項研究
- 頭頸部鱗狀細胞癌8 項研究
- 子宮內膜癌8 項研究
- 心臟衰竭8 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。